F848-0521 Screening compound: N-(1,3-benzothiazol-2-yl)-4-[5-(diethylsulfamoyl)-1H-1,2,3-benzotriazol-1-yl]butanamide

F848-0521 Screening compound: N-(1,3-benzothiazol-2-yl)-4-[5-(diethylsulfamoyl)-1H-1,2,3-benzotriazol-1-yl]butanamide
F848-0521 Screening compound: N-(1,3-benzothiazol-2-yl)-4-[5-(diethylsulfamoyl)-1H-1,2,3-benzotriazol-1-yl]butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F848-0521
N-(1,3-benzothiazol-2-yl)-4-[5-(diethylsulfamoyl)-1H-1,2,3-benzotriazol-1-yl]butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F848-0521

Molecular Formula

C21H24N6O3S2 (C21 H24 N6 O3 S2)

Compound Name

N-(1,3-benzothiazol-2-yl)-4-[5-(diethylsulfamoyl)-1H-1,2,3-benzotriazol-1-yl]butanamide

IUPAC name

N-(13-benzothiazol-2-yl)-4-[5-(diethylsulfamoyl)-1H-123-benzotriazol-1-yl]butanamide

SMILES

CCN(CC)S(c(cc1)cc2c1n(CCCC(Nc1nc(cccc3)c3s1)=O)nn2)(=O)=O

InChI

InChI=1S/C21H24N6O3S2/c1-3-26(4-2)32(29,30)15-11-12-18-17(14-15)24-25-27(18)13-7-10-20(28)23-21-22-16-8-5-6-9-19(16)31-21/h5-6,8-9,11-12,14H,3-4,7,10,13H2,1-2H3,(H,22,23,28)

InChI Key

GRHCFCWUZZAIQC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27199702

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

472.59

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.819

Distribution Coefficient, logD

2.818

Water Solubility, LogSw

-3.45

Polar Surface Area

89.650

Acid Dissociation Constant (pKa)

10.66

Base Dissociation Constant (pKb)

1.08

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

F848-0521 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Lipid Metabolism Library (9174 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with F848-0521 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F848-0521?
Check Price and Availability of F848-0521, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F848-0521 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F848-0521
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F848-0521
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F848-0521 available by request